Be careful with weight loss drugs
-
Yikes.
Lawsuits are piling up against major GLP-1 makers Eli Lilly and Novo Nordisk as more patients accuse popular drugs like Ozempic and Zepbound of permanently damaging their eyesight.
-
OMG!
a 63-year-old man was prescribed Ozempic to manage his diabetes in 2023 and woke up four months later with loss of vision in one eye. He continued taking the medication, not knowing it had been linked to vision problems in some clinical trials and studies, and lost sight in his other eye in October 2024.
"Now legally blind, Engel has had to quit his job and give up his commercial driver’s license. He can’t see his grandkids play baseball, he said, and the couple has shelved much of their retirement travel bucket list," USA TODAY reported.
Ok, also this:
There is currently not enough research to definitively establish a cause-and-effect relationship between GLP-1s and NAION or other vision changes.
But seriously, these glp-1 drugs are so new, doctors should be more cautious about prescribing them, and any new illness or symptom in a person on a glp-1 maybe should lead to increased scrutiny of possible connections.
-
OMG!
a 63-year-old man was prescribed Ozempic to manage his diabetes in 2023 and woke up four months later with loss of vision in one eye. He continued taking the medication, not knowing it had been linked to vision problems in some clinical trials and studies, and lost sight in his other eye in October 2024.
"Now legally blind, Engel has had to quit his job and give up his commercial driver’s license. He can’t see his grandkids play baseball, he said, and the couple has shelved much of their retirement travel bucket list," USA TODAY reported.
Ok, also this:
There is currently not enough research to definitively establish a cause-and-effect relationship between GLP-1s and NAION or other vision changes.
But seriously, these glp-1 drugs are so new, doctors should be more cautious about prescribing them, and any new illness or symptom in a person on a glp-1 maybe should lead to increased scrutiny of possible connections.
But seriously, these glp-1 drugs are so new, doctors should be more cautious about prescribing them, and any new illness or symptom in a person on a glp-1 maybe should lead to increased scrutiny of possible connections.
They’re over 20 years old. It’s just that prescribing them for weight loss is newish. Used to be just diabetes.
-
I strongly suspect that the risk to your health of obesity greatly exceeds the risk of this potential side effect if it is one.
I’m probably more attuned to thinking about relative risks with medications given that I take drugs known to cause chronic kidney disease (with utter certainty, the only question is severity) and increase my skin cancer risk by 100x (not a typo). My alternative would be to die in a couple of months as my body rejects my lungs.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Register Login